Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death

Jinhee Kim1, Nima Ghasemzadeh2, Danny J Eapen2

  • 1Center for Integrative Genomics and School of Biology, Georgia Institute of Technology, Boggs Building 1-96, 770 State Street, Atlanta, GA 30332, USA.

Genome Medicine
|June 28, 2014
PubMed

Insights

Peripheral blood gene expression profiles can predict cardiovascular death risk in coronary artery disease (CAD) patients. This finding may improve risk stratification beyond traditional methods for adverse cardiovascular events.

Area of Science:

  • Cardiovascular Genomics
  • Molecular Diagnostics
  • Translational Medicine

Background:

  • Genetic risk scores for coronary artery disease (CAD) lack predictive power for adverse cardiovascular events.
  • Peripheral blood expression profiles are being investigated as potential predictors of cardiovascular outcomes.

Purpose of the Study:

  • To determine if peripheral blood gene expression profiles can predict acute myocardial infarction (AMI) and/or cardiovascular death.
  • To identify a transcriptional signature associated with cardiovascular mortality in CAD patients.

Main Methods:

  • Peripheral blood samples from 338 CAD subjects were analyzed in discovery (N=175) and replication (N=163) phases.
  • Gene expression was measured using Illumina HT-12 microarrays; whole genome genotyping supported expression quantitative trait loci analysis.
  • Analysis of variance, receiver operating curve, and survival analysis were used to define a cardiovascular death risk signature.

Main Results:

  • Significant differential gene expression was observed between healthy and AMI groups, with altered T-lymphocyte signaling and inflammatory gene expression.
  • A principal component (PC1) score from 238 differentially expressed genes predicted cardiovascular death risk (HR=8.5, P<0.0001) and improved model discrimination (AUC 0.82 to 0.91).
  • Expression quantitative trait loci analysis indicated altered local genetic regulation of transcript abundance in AMI samples.

Conclusions:

  • A specific peripheral blood gene expression profile is associated with significant mortality risk in Caucasian CAD subjects.
  • This profile includes transcripts also altered during acute myocardial infarction.
  • Blood-based gene expression signatures may offer novel avenues for cardiovascular risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
751
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
919
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K